PRODUCT

BioMind® uses artificial intelligence for the analysis of medical images to assist physicians in diagnosis and treatment of patients.

In collaboration with over 200 medical specialists, BioMind integrates advanced machine learning techniques such as deep learning and natural language processing on medical imaging to identify various medical conditions, ranging from neurological disorders to cardiac and lung diseases.

Our flagship product, BioMind, is currently the most mature application of artificial intelligence neuroimaging in the medical field. It is acknowledged as one of the best in many international platforms and has garnered positive resonance amongst many clinicians and experts.

Product

BioMind® uses artificial intelligence for the analysis of medical images to assist physicians in diagnosis and treatment of patients.

In collaboration with over 200 medical specialists, BioMind integrates advanced machine learning techniques such as deep learning and natural language processing on medical imaging to identify various medical conditions, ranging from neurological disorders to cardiac and lung diseases.

Our flagship product, BioMind, is currently the most mature application of artificial intelligence neuroimaging in the medical field. It is acknowledged as one of the best in many international platforms and has garnered positive resonance amongst many clinicians and experts.

IMAGE DIAGNOSIS

AI for Neurological Disorders

BioMind® is able to detect, recognise, and report multiple neurological conditions on MRI, CT, CTA and MRA modalities.

Our applications include assisting in the dianogsis and localisation of tumor, cerebrovascular diseases and stroke. It can be expanded to assist in treatment planning for surgery and radiotherapy.

  • Wide range of intracranial tumors
  • Stroke detection and hematoma expansion prediction
  • Cerebrovascular disease screening
  • Image guided cranial surgery and radiotherapy

BioMind (Domestic Support Solution)
AI for COVID-19 Detection

The COVID-19 outbreak has been declared a pandemic by the World Health Organization. In collaboration with lung specialists from 30 hospitals in ground zero, we have developed BioMind® (COVID-19), the world’s first AI application that detects COVID-19 pneumonia on CT scans in seconds.   

It is also able to differentiate COVID-19 pnuemonia from all other types. This solution has the potential to be upgraded to assist in the differential diagnosis of other pneumonia caused by germs, virus and bacteria. 

  • Triage to prioritize patients
  • Intelligent interlobular analysis
  • Disease Progression Analysis
  • Automated Density Analysis
  • Lesion Mapping and Quantification

AI for Brain Tumor

BioMind uses deep learning techniques to train on a wide pool of neurological disorders data that adheres to international standard.

Based on attention mechanism with fully convolutional network and applying on large volume of MRI scans verified by pathological results, the machine is able to assist in the diagnosis of a wide range of brain tumours.

This is the first AI medical device approved by the China FDA (NMPA), Singapore HSA, Europe CE marking and many other countries. 

AI for Cerebrovascular Disease

Cerebral small vessel disease (CSVD) is the leading cause of stroke, cognitive impairment and depression. MRI scans are used to identify the presence of CSVD, determine the cause or predict the risk of stroke. 

BioMind uses deep learning techniques to analyse multiple sequences of MRI scans from different dimensions.

It is then able to recommend the diagnosis of the corresponding lesions and perform quantitative assessment of the condition all within seconds.

AI for Haemorrhage

Intracerebral hemorrhage is the most disabling and deadly form of stroke, often exacerbated by late treatment and poor prognosis.

Our solution not only aids in fast detection of hemorrhage on CT scans, it identifies the location and evaluates its severity automatically. The risk of hematoma expansion within the next 24 hours can also be predicted to facilitate treatment approaches.

This helps in early detection and accurate prognosis of stroke patients.

AI for Pneumonia

BioMind (COVID-19) is an AI-assisted application to detect COVID-19 pneumonia on CT scans.

The application helps to triage suspected COVID-19 patients, assist in differentiating COVID-19 pneumonia from other types of pneumonia, performs interlobular assessment of lung condition and aid in the disease progression evaluation for follow-up CT scans.

These functions help to speed up the workflow and facilitate early intervention, thus slowing down the spread to community.

Clinical Decision Support System for Ischemic Stroke

Stroke-AI TM is our artificial intelligence-based health IT system designed to provide physicians with smart clinical decision support. It analyses the medical data of patients and determine the type of stroke and suggest treatment approaches.

Based on the pathogenesis and etiology of the disease, it recommends the ischemic stroke subtype (CISS classification), and when combined with the patient’s imaging scans, medical history, complications, and other clinical data, it recommends treatment plans based on international guidelines and scientific literature, and provides complication prediction and management.

RESEARCH USE

AI for Cardiac Diseases

Cardiovascular disease is one of the world’s leading causes of death, yet there is a severe global shortage of heart specialists to deal with the deluge of patients.

Using the power of artificial intelligence and coupling with the clinical experience of specialists, the automated analysis of MRI and ultrasound image has become possible.

The early breakthrough in using deep learning to perform accurate analysis of the heart functions and wall motions, and differential diagnosis of heart diseases including all major types of cardiomyopathy, valvular disease, congenital diseases etc. emphasizes and amplifies the potential capability of machines, to help physicians detect and manage complex heart problems.

AI for Stroke Treatment Recommendation

Acute ischemic stroke is a disease that can result in high morbidity, disability, mortality and recurrence. It remains as the leading cause of death in many countries. 

Stroke-AITM was developed to help doctors by providing personalised treatment plans for stroke patients. As our clinical decision support system (CDSS), Stroke-AITM leverages the use of AI technology to create systems that enable the standardisation of patient management for patients with stroke conditions, and to improve in treatment quality. 

This solution is currently undergoing clinical trials in 50 hospitals.

  AI影像分析

AI image analysis can automatically capture image data and conduct AI analysis using the electronic medical system. 

It can potentially determine the number of infarctions and their positions through identification of the body structure, blood vessels and degree of stenosis.

  AI影像分析

AI影像分析可在电子病历系统自动抓取影像数据并进行AI分析，通过区分结构标识梗死位置、梗死数量；标识责任血管及狭窄程度。

  AI影像分析

AI影像分析可在电子病历系统自动抓取影像数据并进行AI分析，通过区分结构标识梗死位置、梗死数量；标识责任血管及狭窄程度。

  AI影像分析

AI影像分析可在电子病历系统自动抓取影像数据并进行AI分析，通过区分结构标识梗死位置、梗死数量；标识责任血管及狭窄程度。

  AI影像分析

AI影像分析可在电子病历系统自动抓取影像数据并进行AI分析，通过区分结构标识梗死位置、梗死数量；标识责任血管及狭窄程度。

KEY FEATURES

Image Segmentation

3D Reconstruction

  • User-friendly, fast and consistent

BioMind® analyses medical images and recommends a diagnosis within seconds. It automatically generates an editable report for the doctor’s confirmation.

  • Excellent post-sales services

We have an established team to provide reliable after-sales support. This includes regular updates to maintain the quality of your product.

  • Self-learning and improvement

BioMind® has the ability to self-learn and improve through cycles of predictions and doctors’ revisions.

  • User-friendly, fast and consistent

BioMind® analyses medical images and recommends a diagnosis within seconds. It automatically generates an editable report for the doctor’s confirmation.

  • Excellent post-sales services

We have an established team to provide reliable after-sales support. This includes regular updates to maintain the quality of your product.

  • Self-learning and improvement

BioMind® has the ability to self-learn and improve through cycles of predictions and doctors’ revisions.

+65 6821 1272

[email protected]

BioMind Offices

+65 6821 1272

[email protected]

BioMind Offices

China

Beijing BioMind Technology, Zhongguancun Medical Engineering Center, 10 Anxiang Road, 8th floor

Singapore

Hanalytics Pte Ltd 151 Lorong Chuan #03-01C, Lobby A, New Tech Park, Singapore 556741

Europe

Hanalytics SARL House of Biohealth 27-29, rue Henri Koch, L-4354 Esch/Alzette,Luxembourg

Copyright © 2020 BioMind All Rights Reserved | ISO 13485:2016 Certified Organisation | Privacy Policy | Terms of Use